Press Release

DCIIA Elects 2025 Executive Committee

Issued by Defined Contribution Institutional Investment Association [DCIIA]

Jan. 8, 2025

DCIIA is pleased to announce the organization's Executive Committee for the 2025/2026 term. Chair of the Executive Committee is Mike Raso, PineBridge Investments, and Vice Chair is Allegra Heyligers, Allspring Global Investments.

The DCIIA Executive Committee provides strategic direction, input on initiatives, and leadership of the organization’s committees. It is the governing board and primary advisory body for the organization. DCIIA member organizations include investment managers, consultants and advisors, law firms, recordkeepers, insurance companies, research and data providers, plan sponsors, and others committed to the best interests of plan participants.

“These volunteer leaders are an invaluable part of our member-led collaboration in the pursuit of our vision, to bring together constituents across the financial ecosystem to help America's workforce save for retirement and achieve broader financial security,” said Lew Minsky, DCIIA President and CEO.

About DCIIA

Founded in 2010, DCIIA is a non-profit association that brings together constituents across the financial ecosystem to help America's workforce save for retirement and achieve broader financial security. DCIIA’s 300+ member organizations include investment managers, consultants and advisors, law firms, recordkeepers, insurance companies, data providers, plan sponsors (through the Plan Sponsor Institute) and others who are collectively committed to the best interests of America's workforce. DCIIA also conducts proprietary research and participates in industry collaboration on retirement topics via the DCIIA Retirement Research Center. DCIIA is the association partner of the Journal of Retirement. For more information, visit: www.dciia.org.

Editor's note: This press release has been issued by the company named above, not BenefitsLink. Reliance on information in this press release might be prudent only after an independent review of its accuracy, completeness, efficacy, and timeliness. Reference to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer, or otherwise does not constitute or imply endorsement, recommendation, or favoring by BenefitsLink.